Animal studies, including mouse experiments, have suggested that oral infection with this bacterium may increase amyloid-beta production and inflammation in the brain. However, these findings are not yet confirmed in humans.
Researchers also found gingipain-related markers in some individuals without a formal Alzheimer’s diagnosis, which raised questions about whether infection could occur earlier than symptoms appear, or whether poor oral health develops alongside cognitive decline.
While these findings are scientifically interesting, experts emphasize that they do not prove Alzheimer’s is an infectious disease. The condition is widely understood to be complex and likely caused by multiple interacting factors.
Current research is exploring many possible pathways, but no infection-based treatment has been proven effective in humans so far. Most potential therapies are still in early experimental stages.
Overall, the gum disease link is a promising area of study, but it remains one piece of a much larger and still evolving scientific puzzle around Alzheimer’s disease.